BioSpace News Archive

Biorasi , a leading global full-service contract research organization (CRO), announced today that they have selected IBM Watson Health (IBM) as a preferred vendor. This relationship with IBM Watson Health expands Biorasi’s capabilities in clinical trial execution and management through IBM’s Clinical Development (ICD) platform – a clinical data management system (CDMS) designed to help bring efficiency and speed to the clinica

Cerner Corporation, a global health care technology company, announced that William Mintz has joined the company as Chief Strategy Officer.

Xellia Pharmaceuticals Expands Approved Doses of VANCO READY TM (Ready-to-Use Premixed Vancomycin Injection Bags) Additional room temperature stable Vancomycin Injection Premix doses now approved in the US, and available in October 2020 Doses of 1.25 g, 1.75 g and 750 mg ready-to-use Vancomycin premixes In total, 7 VANCO READY TM doses now US FDA approved COPENHAGEN, Denmark--( BUSINESS WIRE )-- Xellia Pharmaceuticals (‘X

Axonics ® to Host Presentation of Full 2-Year Clinical Results from ARTISAN-SNM Pivotal Study on September 9

BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced it will host a call to discuss the results from the

Today, Sonic Healthcare USA (Sonic) was awarded a contract from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics Advanced Technology Platforms (RADx-ATP) initiative.

Furthering its mission to transform the treatment of aortic disorders, Endologix, Inc. (OTC: ELGXQ) (“Endologix” or the “Company”) today announced the first implant of its recently approved ALTO ® endograft outside of the United States, completed by Andrew Holden, MD, and Andrew Hill, MD, of Auckland City Hospital, Auckland, New Zealand. “With the 7 mm infrarenal placement of its sealing ring, ALTO expands the endov

George Clinical, a global scientifically-backed clinical research organization, has expanded the organization’s team in China with the addition of Dr. Zhenfei Yin in the role of Country Head and Regional Head of Project Operations.

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

– NIH grant funds an interdisciplinary effort among researchers from University of Southern California; University of Washington and Fred Hutchinson Cancer Research Center; Harvard University and Massachusetts General Hospital; the Ragon Institute; and Magenta Therapeutics – – Magenta will utilize its tool CD45 and CD117 antibody-drug conjugate (ADC) conditioning agents, as well as its stem cell biology platform to identify the optimal strategy for cur